GlassScriptPhysician profile
James P Pepka
NPI 1821136086
$859.64
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $495 · 2021: $131 · 2023: $17.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $128.13 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $105.80 | 2019-2020 | |
| Daiichi Sankyo INC. | $86.58 | 2020-2021 | |
| Pfizer INC. | $67.00 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $58.10 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $47.12 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $40.16 | 2020-2021 | |
| Abbvie INC. | $38.56 | 2020-2021 | |
| Lilly USA, LLC | $36.27 | 2019-2023 | Amyvid |
| Ironwood Pharmaceuticals, INC | $36.09 | 2020 | |
| Hikma Pharmaceuticals USA | $34.94 | 2019 | |
| Mylan Specialty L.P. | $30.27 | 2020 | |
| Celgene Corporation | $22.79 | 2019 | |
| Amarin Pharma, INC. | $21.61 | 2019 | |
| Esperion Therapeutics, INC. | $19.67 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.48 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.28 | 2021 | |
| Horizon Therapeutics Plc | $14.61 | 2019 | |
| Upsher-Smith Laboratories LLC | $12.90 | 2020 | |
| Eisai INC. | $12.71 | 2020 | |
| Amgen INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pepka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.